Endurance Training and Elite Young AthletesArmstrong N. · Barker A.R.
Children’s Health and Exercise Research Centre, University of Exeter, Exeter, UK
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Endurance training consists of a structured exercise programme that is sustained for a sufficient length of time with sufficient intensity and frequency to induce an improvement in aerobic fitness. Elite young athletes generally have higher peak oxygen uptakes (peak VO2) than their untrained peers largely due to their greater maximal stroke volumes. Trained young athletes have faster VO2 kinetic responses to step changes in exercise intensity but whether this is due to enhanced oxygen delivery or increased oxygen utilization by the muscles remains to be explored. Blood lactate accumulation in young athletes during submaximal exercise is lower than in untrained youth and this appears to be due to enhanced oxidative function in the active muscles. No well-designed, longitudinal endurance training studies of elite young athletes have been published. Even in the general paediatric population peak VO2 is the only component of aerobic fitness on which there are sufficient data to examine dose-response effects of endurance training. The existence of a maturational threshold below which children are not trainable remains to be proven. The magnitude of training responses is independent of sex. Pre-training peak VO2 has a moderate but significant inverse relationship with post-training peak VO2 which suggests that elite young athletes are likely to experience smaller increases in peak VO2 with further endurance training than untrained youth. Empirical evidence strongly indicates that both trained and untrained young people can benefit from endurance training but the relative intensity of exercise required for optimum benefits is higher than that recommended for adults.
© 2011 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.